Regeneron (REGN) announced updated data for the investigational gene therapy DB-OTO from the Phase 1/2 CHORD trial in 12 children who have profo ...

--Regeneron Pharmaceuticals, Inc. today announced updated data for the investigational gene therapy DB-OTO from the Phase 1/ 2 CHORD trial in 12 children who have profound genetic hearing loss due ...

I n this lesson, I’d like to discuss playing over what’s known as a I - VI - II - V (“one-six-two-five”) chord progression, which is common in a variety of musical styles, from country to rock to folk ...